Go to the list of all blogs
published in Blogs
Jul 14, 2026
MP Materials (MP) Stock Drops -14% Over 30 Days on China Blacklist and Insider Selling

MP Materials (MP) Stock Drops -14% Over 30 Days on China Blacklist and Insider Selling

Key Takeaways

  • MP Materials shares declined approximately 14% over the past 30 days, falling from $57.55 on June 12 to $49.50 as of July 13, 2026.
  • China's decision to add MP Materials to its export-control blacklist in late June triggered a sharp selloff despite the company's limited direct exposure to Chinese supply chains.
  • Elevated insider selling — with over 1.2 million shares sold by executives including the CEO and CFO in the last quarter — weighed on investor confidence.
  • Broader macro headwinds, including basic materials sector weakness and renewed geopolitical tensions, compounded the downward pressure.
  • Despite the pullback, Wall Street analysts maintain a consensus "Buy" rating with an average price target of approximately $79.54, suggesting significant upside from current levels.

MP Materials (MP) Company Overview and Market Position

MP Materials Corporation is a vertically integrated rare earth materials producer and the operator of the Mountain Pass Rare Earth Mine and Processing Facility in California — the only commercially viable rare earth mining and processing site in the United States. The company extracts, separates, and refines critical rare earth elements including neodymium, praseodymium, and cerium, which serve as essential inputs for permanent magnets used across electric vehicles, wind turbines, defense systems, robotics, and advanced electronics. MP Materials has strategically expanded downstream into magnet manufacturing through its Independence Facility and the planned 10X Facility in Northlake, Texas, positioning itself as a cornerstone of the U.S. effort to reshore domestic critical-mineral supply chains. With long-term agreements in place with the U.S. Department of Defense, AAPL, and GM, the company benefits from both government backing and commercial demand visibility. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

MP Materials (MP) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, MP Materials stock fell roughly 14%, declining from a closing price of $57.55 on June 12 to $49.50 on July 13, 2026. The decline was punctuated by a series of sharp single-day drops, including a 5.1% slide on July 13 alone, as a combination of geopolitical and company-specific headwinds weighed on sentiment. Looking at the broader quarterly picture, shares dropped approximately 13.7% from the $57.36 level recorded in mid-April, erasing gains that had pushed the stock toward the $72 mark in early June. The stock currently trades below both its 50-day moving average of $60.30 and its 200-day moving average of $59.38, signaling sustained technical weakness across multiple timeframes.

What Drove MP Stock Price in the Last 30 Days

The primary catalyst for the 30-day selloff was China's June 22 decision to place MP Materials on its export-control blacklist, restricting the flow of dual-use items and Chinese-origin components to the company. While MP Materials does not directly buy or sell to China, the ban creates secondary complications — equipment suppliers or partners using Chinese-made components may face restrictions on selling to MP, introducing potential operational friction and cost increases. The news was interpreted by markets as a near-term headwind, triggering a 13.4% decline during the month of June alone. Compounding the pressure, heightened insider selling drew investor scrutiny. CEO James Litinsky sold approximately 185,000 shares in early June, CFO Ryan Corbett sold 20,000 shares in May, and total insider sales exceeded 1.2 million shares worth roughly $79 million over the last quarter. Although some transactions occurred under pre-arranged trading plans, the activity contributed to negative sentiment. Broader macro headwinds — including weakness in the basic materials sector, elevated inflation expectations, and renewed U.S.-Iran geopolitical tensions — further dampened risk appetite. Additionally, several analysts trimmed their price targets in early July, with DB lowering its target from $70 to $61 and GS adjusting from $80 to $70, reflecting caution around near-term cost pressures and execution risks.

What Drove MP Stock Performance Over the Last Quarter

MP Materials' quarterly performance reflects a tug-of-war between tangible operational progress and persistent profitability concerns. The company delivered a strong Q1 2026 earnings report in early May, posting $90.6 million in revenue — a 49% year-over-year increase — and record NdPr production of 917 metric tons, up 63% from the prior year. Adjusted EBITDA swung positive to $36.6 million, and the company beat consensus EPS estimates by $0.04. These results initially propelled shares toward the $72 level in early June, supported by upbeat analyst commentary from firms including Wedbush and MS. However, enthusiasm faded as investors focused on the 11th consecutive quarter of operating losses, surging start-up and advanced-project costs tied to the 10X magnet facility, and downward revisions to forward earnings estimates. The stock's premium valuation — trading at a forward price/sales multiple above 14X versus an industry average under 2X — made it vulnerable to the risk-off shift triggered by China's export blacklist and the broader sector rotation away from high-growth, pre-profit names.

Exploring Tickeron’s Trending AI Robots

Navigating the volatility in stocks like MP Materials can be challenging, but technology-driven tools are increasingly helping traders identify opportunities in real time. From what I see, Tickeron's Trending AI Robots page curates a select group of top-performing AI trading bots from a library of hundreds that actively trade thousands of tickers across diverse market conditions. These bots employ varied strategies — from short-term momentum plays to longer-duration trend-following approaches — and are ranked by performance metrics so that only the most relevant and consistently effective bots appear in the curated section. For traders seeking data-driven signals to complement their own research, exploring the Trending AI Robots page can offer a practical window into how AI-powered strategies are adapting to current market dynamics. I’m watching this closely as part of my regular process.

MP Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, MP Materials' trajectory will likely hinge on several key factors. The company's next quarterly earnings report will be critical, with investors watching for continued NdPr production growth, progress on the Independence and 10X magnet facilities, and any improvement in operating margins as scale increases. Updates on the implementation and impact of China's export blacklist restrictions — particularly whether equipment procurement timelines face delays — will also draw close scrutiny. On the geopolitical front, any escalation or easing of U.S.-China trade tensions around rare earth supply chains could materially shift sentiment. The G7's commitment to cap rare-earth reliance on non-partner countries below 60% by 2030 represents a structural tailwind that may benefit domestic producers like MP Materials over the longer term. Additionally, institutional positioning, insider transaction patterns, and analyst estimate revisions will remain important signals for gauging market conviction as the company progresses toward its ambitious magnet production targets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MP

MP's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MP turned positive on August 03, 2026. Looking at past instances where MP's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on MP as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MP moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MP advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MP broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MP entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.028) is normal, around the industry mean (11.597). MP's P/E Ratio (770.500) is considerably higher than the industry average of (130.727). MP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.292). MP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (32.051) is also within normal values, averaging (283.267).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Vale SA (NYSE:VALE).

Industry description

The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.

Market Cap

The average market capitalization across the Other Metals/Minerals Industry is 9.57B. The market cap for tickers in the group ranges from 230 to 229.41B. BHP holds the highest valuation in this group at 229.41B. The lowest valued company is BAJFF at 230.

High and low price notable news

The average weekly price growth across all stocks in the Other Metals/Minerals Industry was 5%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was -15%. WWR experienced the highest price growth at 40%, while EMAT experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Other Metals/Minerals Industry was -18%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 78
Price Growth Rating: 55
SMR Rating: 92
Profit Risk Rating: 86
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
MP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry OtherMetalsMinerals

Profile
Details
Industry
N/A
Address
1700 S. Pavilion Center Drive, 8th Floor
Phone
+1 702 844-6111
Employees
681
Web
https://www.mpmaterials.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.